Figure 2
Figure 2. FLT3 ITD mediates generation of high levels of ROS. ROS production in 32D cells (A) or human myeloid cell lines (B) expressing either WT FLT3 or FLT3 ITD (as indicated) was measured with 2 × 106 cells per point using 5-(and-6)-carboxy-2′,7′-difluorodihydrofluorescein diacetate (carboxy-H2DFFDA) in a fluorescence plate reader (mean ± SD, determination in triplicates, representative experiment of 3 with consistent results). (C) Elevated ROS production in AML patient blasts harboring FLT3 ITD. AML patient blasts were isolated from freshly taken blood samples. ROS levels were measured in a fluorescence plate reader using carboxy-H2DFFDA. Values for 10 or 7 patients, harboring FLT3 WT or FLT3 ITD, respectively, are shown (significance tested by t test). Further data of the individual patients are provided in supplemental Figure 4.

FLT3 ITD mediates generation of high levels of ROS. ROS production in 32D cells (A) or human myeloid cell lines (B) expressing either WT FLT3 or FLT3 ITD (as indicated) was measured with 2 × 106 cells per point using 5-(and-6)-carboxy-2′,7′-difluorodihydrofluorescein diacetate (carboxy-H2DFFDA) in a fluorescence plate reader (mean ± SD, determination in triplicates, representative experiment of 3 with consistent results). (C) Elevated ROS production in AML patient blasts harboring FLT3 ITD. AML patient blasts were isolated from freshly taken blood samples. ROS levels were measured in a fluorescence plate reader using carboxy-H2DFFDA. Values for 10 or 7 patients, harboring FLT3 WT or FLT3 ITD, respectively, are shown (significance tested by t test). Further data of the individual patients are provided in supplemental Figure 4.

Close Modal

or Create an Account

Close Modal
Close Modal